These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 21423353)

  • 1. Anti- or profibrillatory effects of Na(+) channel blockade depend on the site of application relative to gradients in repolarization.
    Coronel R; Wilms-Schopman FJ; Janse MJ
    Front Physiol; 2010; 1():10. PubMed ID: 21423353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antifibrillatory and profibrillatory actions of selected class I antiarrhythmic agents.
    Fagbemi SO; Chi L; Lucchesi BR
    J Cardiovasc Pharmacol; 1993 May; 21(5):709-19. PubMed ID: 7685439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction of dispersion of repolarization and prolongation of postrepolarization refractoriness explain the antiarrhythmic effects of quinidine in a model of short QT syndrome.
    Milberg P; Tegelkamp R; Osada N; Schimpf R; Wolpert C; Breithardt G; Borggrefe M; Eckardt L
    J Cardiovasc Electrophysiol; 2007 Jun; 18(6):658-64. PubMed ID: 17521304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiarrhythmic effect of antazoline in experimental models of acquired short- and long-QT-syndromes.
    Ellermann C; Sterneberg M; Kochhäuser S; Dechering DG; Fehr M; Eckardt L; Frommeyer G
    Europace; 2018 Oct; 20(10):1699-1706. PubMed ID: 29377987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiarrhythmic properties of ivabradine in an experimental model of Short-QT- Syndrome.
    Frommeyer G; Weller J; Ellermann C; Kaese S; Kochhäuser S; Lange PS; Dechering DG; Eckardt L
    Clin Exp Pharmacol Physiol; 2017 Sep; 44(9):941-945. PubMed ID: 28556923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ranolazine and Vernakalant Prevent Ventricular Arrhythmias in an Experimental Whole-Heart Model of Short QT Syndrome.
    Frommeyer G; Ellermann C; Dechering DG; Kochhäuser S; Bögeholz N; Güner F; Leitz P; Pott C; Eckardt L
    J Cardiovasc Electrophysiol; 2016 Oct; 27(10):1214-1219. PubMed ID: 27283775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiarrhythmic drug effects on premature beats are partly determined by prior cardiac activation frequency in perfused guinea-pig heart.
    Osadchii OE
    Exp Physiol; 2020 May; 105(5):819-830. PubMed ID: 32175633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiarrhythmic agent, MS-551, protects against pinacidil + hypoxia-induced ventricular fibrillation in Langendorff-perfused rabbit isolated heart.
    Friedrichs GS; Chi L; Black SC; Manley PJ; Lucchesi BR
    J Cardiovasc Pharmacol; 1994 Jan; 23(1):120-6. PubMed ID: 7511723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sodium channel block by ranolazine in an experimental model of stretch-related atrial fibrillation: prolongation of interatrial conduction time and increase in post-repolarization refractoriness.
    Milberg P; Frommeyer G; Ghezelbash S; Rajamani S; Osada N; Razvan R; Belardinelli L; Breithardt G; Eckardt L
    Europace; 2013 May; 15(5):761-9. PubMed ID: 23376977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dispersion of repolarization and arrhythmogenesis.
    Coronel R; Wilms-Schopman FJ; Opthof T; Janse MJ
    Heart Rhythm; 2009 Apr; 6(4):537-43. PubMed ID: 19324316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Actions of pinacidil at a reduced potassium concentration: a direct cardiac effect possibly involving the ATP-dependent potassium channel.
    Chi L; Black SC; Kuo PI; Fagbemi SO; Lucchesi BR
    J Cardiovasc Pharmacol; 1993 Feb; 21(2):179-90. PubMed ID: 7679150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of ventricular proarrhythmia with selective opening of the myocardial sarcolemmal versus mitochondrial ATP-gated potassium channel.
    Fischbach PS; White A; Barrett TD; Lucchesi BR
    J Pharmacol Exp Ther; 2004 May; 309(2):554-9. PubMed ID: 14747611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of the JT Peak Interval and the JT Area in Determining the Proarrhythmic Potential of QT-Shortening Agents.
    Qiu B; Wang Y; Li C; Guo H; Xu Y
    J Cardiovasc Pharmacol Ther; 2019 Mar; 24(2):160-171. PubMed ID: 30092655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Broad antiarrhythmic effect of mexiletine in different arrhythmia models.
    Frommeyer G; Garthmann J; Ellermann C; Dechering DG; Kochhäuser S; Reinke F; Köbe J; Wasmer K; Eckardt L
    Europace; 2018 Aug; 20(8):1375-1381. PubMed ID: 29016765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electrophysiological profile of vernakalant in an experimental whole-heart model: the absence of proarrhythmia despite significant effect on myocardial repolarization.
    Frommeyer G; Milberg P; Clauss C; Schmidt M; Ramtin S; Kaese S; Grundmann F; Grotthoff JS; Pott C; Eckardt L
    Europace; 2014 Aug; 16(8):1240-8. PubMed ID: 24696223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New insights into the beneficial electrophysiologic profile of ranolazine in heart failure: prevention of ventricular fibrillation with increased postrepolarization refractoriness and without drug-induced proarrhythmia.
    Frommeyer G; Rajamani S; Grundmann F; Stypmann J; Osada N; Breithardt G; Belardinelli L; Eckardt L; Milberg P
    J Card Fail; 2012 Dec; 18(12):939-49. PubMed ID: 23207083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanically Induced Ectopy via Stretch-Activated Cation-Nonselective Channels Is Caused by Local Tissue Deformation and Results in Ventricular Fibrillation if Triggered on the Repolarization Wave Edge (Commotio Cordis).
    Quinn TA; Jin H; Lee P; Kohl P
    Circ Arrhythm Electrophysiol; 2017 Aug; 10(8):e004777. PubMed ID: 28794084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ivabradine Reduces Digitalis-induced Ventricular Arrhythmias.
    Frommeyer G; Weller J; Ellermann C; Bögeholz N; Leitz P; Dechering DG; Kochhäuser S; Wasmer K; Eckardt L
    Basic Clin Pharmacol Toxicol; 2017 Dec; 121(6):526-530. PubMed ID: 28627809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disappearance with ischaemic depolarization of the antifibrillatory activity in a sodium channel blocker and appearance in calcium channel blocker.
    Bui-Xuan B; Aupetit JF; Freysz M; Loufoua-Moundanga J; Faucon G; Timour Q
    Arch Int Pharmacodyn Ther; 1996; 331(3):246-62. PubMed ID: 9124997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new mechanism preventing proarrhythmia in chronic heart failure: rapid phase-III repolarization explains the low proarrhythmic potential of amiodarone in contrast to sotalol in a model of pacing-induced heart failure.
    Frommeyer G; Milberg P; Witte P; Stypmann J; Koopmann M; Lücke M; Osada N; Breithardt G; Fehr M; Eckardt L
    Eur J Heart Fail; 2011 Oct; 13(10):1060-9. PubMed ID: 21873342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.